Target intelligence / Profile preview

Sertoli cells and spermatogonia

Molecular classification
Cell type, Tissue component
01

Overview

Sertoli cells and spermatogonia are the fundamental cellular components of the seminiferous tubules responsible for male fertility. Sertoli cells, often referred to as nurse cells, provide the necessary microenvironment, structural support, and nutritional requirements for the development of germ cells (Griswold, 1998; StatPearls, 2023). Spermatogonia are the diploid germline stem cells that undergo self-renewal and differentiation to eventually produce mature spermatozoa (Kanatsu-Shinohara & Shinohara, 2013). This cellular system is highly sensitive to hormonal regulation by the hypothalamic-pituitary-gonadal axis and is a primary site of toxicity for many chemotherapeutic agents (O'Shaughnessy, 2014). Although they are not a single molecular target, their interaction is critical for spermatogenesis, and their dysfunction is a hallmark of various forms of male infertility and testicular cancer (Meistrich, 2013). Understanding the signaling between these cells is vital for developing male contraceptives and treating idiopathic infertility.

Other names
Sertoli-germ cell unitSeminiferous epitheliumSpermatogenic niche
02

Mechanism of action

Drugs typically act on specific receptors within these cells, such as the follicle-stimulating hormone receptor (FSHR) or androgen receptor (AR) on Sertoli cells, to modulate the spermatogenic environment, or act as cytotoxic agents that deplete the spermatogonia population (O'Shaughnessy, 2014; Meistrich, 2013).

03

Biological functions

SpermatogenesisBlood-testis barrier formationGerm cell supportHormonal regulationCell proliferation
04

Disease associations

Male infertilitySertoli cell-only syndromeAzoospermiaTesticular germ cell cancer
05

Safety considerations

Permanent infertilityAzoospermiaTesticular atrophyEndocrine disruption
06

Interacting drugs

Follicle-stimulating hormone

3 more in the full profile.

07

Biomarkers

Inhibin BAnti-Müllerian hormoneMAGE-A4VimentinTransferrin

Beyond the preview

Go deeper on Sertoli cells and spermatogonia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sertoli cells and spermatogonia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call